Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL): Results from the phase 2 DELPHINUS study Meeting Abstract
| Authors: | Hogan, L. E.; Bhatla, T.; Teachey, D. T.; Sirvent, F. J. B.; Moppett, J.; Puyó, P. V.; Micalizzi, C.; R?Ssig, C. R.; Shukla, N.; Gilad, G.; Locatelli, F.; Baruchel, A.; Zwaan, C. M.; Raetz, E. A.; Bandyopadhyay, N.; Solano, L. L.; Dennis, R. M.; Carson, R. L.; Vora, A. |
| Abstract Title: | Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL): Results from the phase 2 DELPHINUS study |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300004 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.10001 |
| Notes: | Meeting Abstract: 10001 -- Meeting also held virtually -- Source: Wos |
